Qube Research & Technologies LTD Anika Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 7,986 shares of ANIK stock, worth $202,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,986
Previous 18,451
56.72%
Holding current value
$202,524
Previous $468,000
56.84%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANIK
# of Institutions
116Shares Held
11.8MCall Options Held
2.7KPut Options Held
5K-
Trigran Investments, Inc.2.14MShares$54.2 Million5.66% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$40.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA790KShares$20 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX749KShares$19 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny598KShares$15.2 Million0.03% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $370M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...